Ryan S. Alden

Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer

Geoffrey R. Oxnard, Kenneth S. Thress, Ryan S. Alden et al. · Journal of Clinical Oncology · 2016 · 836 citations · Full text

Prospective Validation of Rapid Plasma Genotyping for the Detection of<i>EGFR</i>and<i>KRAS</i>Mutations in Advanced Lung Cancer

Adrian G. Sacher, Cloud P. Paweletz, Suzanne E. Dahlberg et al. · JAMA Oncology · 2016 · 558 citations

Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

Cloud P. Paweletz, Adrian G. Sacher, Chris K. Raymond et al. · Clinical Cancer Research · 2015 · 239 citations · Full text

Acquired <i>MET</i> D1228V Mutation and Resistance to MET Inhibition in Lung Cancer

Magda Bahcall, Taebo Sim, Cloud P. Paweletz et al. · Cancer Discovery · 2016 · 170 citations · Full text

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium

B.T. Li, Filip Jankú, B. Jung et al. · Annals of Oncology · 2019 · 154 citations · Full text